Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models
暂无分享，去创建一个
E. Bonora | S. Meijer | W. Phillips | M. I. van Berge Henegouwen | S. Mattioli | S. Calpe | S. Gisbertz | K. Krishnadath | D. Liu | M. Read | M. Sancho-Serra | S. Hoefnagel | Ana C. P. Correia | Shulin Li | M. D. C. Sancho-Serra